MicroCloud Hologram Inc. (NASDAQ: HOLO), ("HOLO" or the "Company"), a technology service provider, delved deeply ...
Chinese biotech company Akeso developed a lung cancer drug Ivonescimab, which outperformed Merck's Keytruda in trials. This ...
In February, The National Interest organized a symposium on the U.S.-China technology race amidst the emergence of DeepSeek ...